Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.

Biajoux V, Bignon A, Freitas C, Martinez V, Thelen M, Lima G, Jakez-Ocampo J, Emilie D, Llorente L, Balabanian K.

J Transl Med. 2012 Dec 18;10:251. doi: 10.1186/1479-5876-10-251.

2.

CXCR7 influences the migration of B cells during maturation.

Humpert ML, Pinto D, Jarrossay D, Thelen M.

Eur J Immunol. 2014 Mar;44(3):694-705. doi: 10.1002/eji.201343907. Epub 2014 Feb 19.

3.

Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus.

Wang A, Guilpain P, Chong BF, Chouzenoux S, Guillevin L, Du Y, Zhou XJ, Lin F, Fairhurst AM, Boudreaux C, Roux C, Wakeland EK, Davis LS, Batteux F, Mohan C.

Arthritis Rheum. 2010 Nov;62(11):3436-46. doi: 10.1002/art.27685.

4.

Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.

Liberman J, Sartelet H, Flahaut M, Mühlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM, Gross N.

PLoS One. 2012;7(8):e43665. doi: 10.1371/journal.pone.0043665. Epub 2012 Aug 20.

5.
6.

Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.

Hansen A, Reiter K, Ziprian T, Jacobi A, Hoffmann A, Gosemann M, Scholze J, Lipsky PE, Dörner T.

Arthritis Rheum. 2005 Jul;52(7):2109-19.

7.

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.

Chong BF, Mohan C.

Expert Opin Ther Targets. 2009 Oct;13(10):1147-53. doi: 10.1517/14728220903196761. Review.

PMID:
19670960
8.

Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.

Boudot A, Kerdivel G, Habauzit D, Eeckhoute J, Le Dily F, Flouriot G, Samson M, Pakdel F.

PLoS One. 2011;6(6):e20898. doi: 10.1371/journal.pone.0020898. Epub 2011 Jun 10.

9.

Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease.

Werner L, Elad H, Brazowski E, Tulchinsky H, Vigodman S, Kopylov U, Halpern Z, Guzner-Gur H, Dotan I.

J Leukoc Biol. 2011 Sep;90(3):583-90. doi: 10.1189/jlb.0111101. Epub 2011 May 31.

PMID:
21628333
10.

Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.

Papadimitraki ED, Choulaki C, Koutala E, Bertsias G, Tsatsanis C, Gergianaki I, Raptopoulou A, Kritikos HD, Mamalaki C, Sidiropoulos P, Boumpas DT.

Arthritis Rheum. 2006 Nov;54(11):3601-11.

11.

CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein.

McGinn OJ, Marinov G, Sawan S, Stern PL.

J Cell Sci. 2012 Nov 15;125(Pt 22):5467-78. doi: 10.1242/jcs.109488. Epub 2012 Sep 6.

12.

Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus.

Hanaoka H, Okazaki Y, Hashiguchi A, Yasuoka H, Takeuchi T, Kuwana M.

Clin Exp Rheumatol. 2015 Nov-Dec;33(6):863-70. Epub 2015 Aug 31.

PMID:
26320881
13.

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus.

Daridon C, Blassfeld D, Reiter K, Mei HE, Giesecke C, Goldenberg DM, Hansen A, Hostmann A, Frölich D, Dörner T.

Arthritis Res Ther. 2010;12(6):R204. doi: 10.1186/ar3179. Epub 2010 Nov 4.

14.

Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.

Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.

J Eur Acad Dermatol Venereol. 2009 Apr;23(4):433-7. doi: 10.1111/j.1468-3083.2009.03095.x.

PMID:
19335730
15.

CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.

Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B.

Blood. 2009 Jun 11;113(24):6085-93. doi: 10.1182/blood-2008-12-196618. Epub 2009 Apr 20.

16.

The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population.

Wu O, Chen GP, Chen H, Li XP, Xu JH, Zhao SS, Sheng J, Feng JB, Cai J, Fang XH, Zhang WH, Li LH, Zhang N, Li J, Li JJ, Pan FM, Wang CZ, Ye DQ.

Immunobiology. 2009;214(5):392-402. doi: 10.1016/j.imbio.2008.10.004. Epub 2008 Dec 5.

PMID:
19362685
17.

Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.

Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S.

Mol Immunol. 2013 Dec;56(4):574-82. doi: 10.1016/j.molimm.2013.05.241. Epub 2013 Aug 1.

PMID:
23911415
18.

Rapid uptake and degradation of CXCL12 depend on CXCR7 carboxyl-terminal serine/threonine residues.

Hoffmann F, Müller W, Schütz D, Penfold ME, Wong YH, Schulz S, Stumm R.

J Biol Chem. 2012 Aug 17;287(34):28362-77. doi: 10.1074/jbc.M111.335679. Epub 2012 Jun 26.

19.

CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.

Chen N, Jiang X, Wang J, Wu T, Cheng B, Xia J.

Tumour Biol. 2016 Jan;37(1):567-75. doi: 10.1007/s13277-015-3803-6. Epub 2015 Aug 2.

PMID:
26232325
20.

MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP-70 signaling, and lymphocyte chemotaxis.

Alampour-Rajabi S, El Bounkari O, Rot A, Müller-Newen G, Bachelerie F, Gawaz M, Weber C, Schober A, Bernhagen J.

FASEB J. 2015 Nov;29(11):4497-511. doi: 10.1096/fj.15-273904. Epub 2015 Jul 2.

Supplemental Content

Support Center